Check out the original article from the Lancet Haematology here.
RELATED REPORTS
Tags: autologous stem cell transplantationblood cancerbortezomibcancercancer progressionchemochemotherapydexamethasonedouble autologous haematopoietic stem-cell transplantationhaematopoietic stem cell transplantationhematologyhematopoietic cell transplantationHematopoietic stem-cell transplantationHSCTmalignancyMMmultiple myelomamyelomaoncologyoverall survivalprogression-free survivalsecond primary malignanciesstem cell transplantstem cell transplantationsurvival outcomesthalidomidevtd


![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)




